Published in Rheumatology (Oxford) on January 27, 2011
The relation of sexual function to migraine-related disability, depression and anxiety in patients with migraine. J Headache Pain (2014) 0.81
Sexual activity and impairment in women with systemic sclerosis compared to women from a general population sample. PLoS One (2012) 0.78
Body image and its relationship with sexual function and marital adjustment in infertile women. Iran J Nurs Midwifery Res (2014) 0.76
Sexual dysfunction in married women with Systemic Sclerosis. Pan Afr Med J (2014) 0.75
Cross-Cultural Adaptation of the Male Genital Self-Image Scale in Iranian Men. Sex Med (2016) 0.75
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
The McGill Pain Questionnaire: major properties and scoring methods. Pain (1975) 14.75
The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther (2000) 13.16
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum (2003) 3.84
Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol (2000) 3.39
Body image and sexual problems in young women with breast cancer. Psychooncology (2006) 2.42
Impaired sexual function in women with systemic sclerosis: a cross-sectional study. Arthritis Rheum (2009) 1.49
Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol (2003) 1.36
The (mis)measurement of body image: ten strategies to improve assessment for applied and research purposes. Body Image (2004) 1.33
Sexual difficulties of chronic pain patients. Clin J Pain (2001) 1.25
Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol (2003) 1.21
The association between sexual satisfaction and body image in women. J Sex Med (2009) 1.18
Psychologic factors in scleroderma. Rheum Dis Clin North Am (2003) 1.12
Body image in women treated for breast cancer. Nurs Res (1993) 1.06
Genital tract abnormalities and female sexual function impairment in systemic sclerosis. Am J Obstet Gynecol (1995) 1.05
Sexual dysfunction and chronic pain: the role of psychological variables and impact on quality of life. Eur J Pain (2005) 1.05
Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda. Arthritis Care Res (Hoboken) (2010) 1.03
Effects of rheumatoid arthritis on sexual activity and relationships. Rheumatology (Oxford) (2003) 1.03
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol (2007) 1.00
Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol (2009) 0.98
Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted Satisfaction with Appearance Scale. Body Image (2007) 0.97
Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken) (2010) 0.96
Sexuality and chronic pain. Am J Nurs (2003) 0.90
Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil (2004) 0.89
Sexual activity and functioning in female scleroderma patients. Clin Exp Rheumatol (2009) 0.88
Gynaecologic history in systemic sclerosis. Clin Rheumatol (2000) 0.88
(Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples. Rheumatology (Oxford) (2009) 0.87
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain (2005) 11.80
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache (2014) 4.25
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev (2004) 3.25
Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res (2013) 2.78
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet (2010) 2.61
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58
The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep (2007) 2.53
Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science (2013) 2.46
Duration of sleep contributes to next-day pain report in the general population. Pain (2008) 2.35
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis (2010) 2.30
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23
Utility of the Patient Health Questionnaire-9 to assess suicide risk in patients with systemic sclerosis. Arthritis Care Res (Hoboken) (2013) 2.14
Is longer-term psychodynamic psychotherapy more effective than shorter-term therapies? Review and critique of the evidence. Psychother Psychosom (2010) 2.10
Routine screening for depression in patients with coronary heart disease never mind. J Am Coll Cardiol (2009) 1.99
Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Rheum (2006) 1.98
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum (2002) 1.91
Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma. Nature (2013) 1.86
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry (2011) 1.85
Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol (2011) 1.80
Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc (2002) 1.75
Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol (2006) 1.73
Ain't necessarily so: review and critique of recent meta-analyses of behavioral medicine interventions in health psychology. Health Psychol (2010) 1.71
A new program in pain medicine for medical students: integrating core curriculum knowledge with emotional and reflective development. Pain Med (2011) 1.70
Brief, four-session group CBT reduces binge eating behaviors among bariatric surgery candidates. Surg Obes Relat Dis (2009) 1.69
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol (2005) 1.66
Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma. Rheum Dis Clin North Am (2003) 1.65
Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology (2008) 1.65
The association of depression with adherence to antihypertensive medications: a systematic review. J Hypertens (2010) 1.54
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2009) 1.53
Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss. Arthritis Rheum (2002) 1.53
Catastrophizing as a mediator of sex differences in pain: differential effects for daily pain versus laboratory-induced pain. Pain (2004) 1.53
Correlates of functional disability in patients with postural tachycardia syndrome: preliminary cross-sectional findings. Health Psychol (2003) 1.51
Catastrophizing delays the analgesic effect of distraction. Pain (2010) 1.50
Pilot evaluation of a substance abuse prevention group intervention for at-risk bariatric surgery candidates. Surg Obes Relat Dis (2013) 1.45
Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.44
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA (2011) 1.44
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum (2005) 1.42
Retracted Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci U S A (2002) 1.41
Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization. Arthritis Rheum (2013) 1.41
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum (2009) 1.40
The brain and the heart: the twain meet. Eur Heart J (2005) 1.39
Sleep disorders and their association with laboratory pain sensitivity in temporomandibular joint disorder. Sleep (2009) 1.38
Association of catastrophizing with interleukin-6 responses to acute pain. Pain (2008) 1.32
Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol (2003) 1.31
Pain-related catastrophizing in healthy women is associated with greater temporal summation of and reduced habituation to thermal pain. Clin J Pain (2006) 1.29
Burn rehabilitation: state of the science. Am J Phys Med Rehabil (2006) 1.29
Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice. PLoS Med (2005) 1.28
Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl Res (2008) 1.27
Episodic migraine and obesity and the influence of age, race, and sex. Neurology (2013) 1.24
Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol (2002) 1.23
Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum (2013) 1.23
Pain sensitivity and pain reactivity in osteoarthritis. Arthritis Care Res (Hoboken) (2010) 1.21
Associations between catastrophizing and endogenous pain-inhibitory processes: sex differences. J Pain (2008) 1.21
Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol (2003) 1.21
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail (2013) 1.21
Finding what is not there: unwarranted claims of an effect of psychosocial intervention on recurrence and survival. Cancer (2009) 1.20
Concordance and discrepancy in sexual identity, attraction, and behavior among adolescents. J Adolesc Health (2009) 1.18
Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum (2009) 1.18
Enhanced reactivity to pain in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.16
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) (2010) 1.15
Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford) (2010) 1.15
Situational versus dispositional measurement of catastrophizing: associations with pain responses in multiple samples. J Pain (2010) 1.15
Pain-related catastrophizing and perceived social responses: Inter-relationships in the context of chronic pain. Pain (2006) 1.14
Catastrophizing and depressive symptoms as prospective predictors of outcomes following total knee replacement. Pain Res Manag (2009) 1.14
The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res (2011) 1.12
Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology (2006) 1.12
Acute pain at discharge from hospitalization is a prospective predictor of long-term suicidal ideation after burn injury. Arch Phys Med Rehabil (2007) 1.12
Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis. J Rheumatol (2003) 1.11
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ (2012) 1.11
Using the cultural formulation to resolve uncertainty in diagnoses of psychosis among ethnoculturally diverse patients. Psychiatr Serv (2012) 1.10
Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol (2009) 1.10
Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum (2003) 1.10
Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases. J Heart Lung Transplant (2005) 1.09
Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine (Baltimore) (2008) 1.09
Suicidal ideation in outpatients with chronic musculoskeletal pain: an exploratory study of the role of sleep onset insomnia and pain intensity. Clin J Pain (2004) 1.09
Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation. J Rheumatol (2002) 1.08
The impact of pain and symptoms of depression in scleroderma. Pain (2002) 1.08
The PHQ-9 versus the PHQ-8--is item 9 useful for assessing suicide risk in coronary artery disease patients? Data from the Heart and Soul Study. J Psychosom Res (2012) 1.07
Reassessing the clinical utility of the Patient Health Questionnaire (PHQ)-9 for depression screening in prenatal women: a commentary on Sidebottom et al. Arch Womens Ment Health (2013) 1.07
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain (2013) 1.06
Suicidal ideation and attempt among adolescents reporting "unsure" sexual identity or heterosexual identity plus same-sex attraction or behavior: forgotten groups? J Am Acad Child Adolesc Psychiatry (2010) 1.04
Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda. Arthritis Care Res (Hoboken) (2010) 1.03
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum (2006) 1.03
Associations between family support, family intimacy, and neighborhood violence and physical activity in urban adolescent girls. Am J Public Health (2006) 1.03
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Arthritis Rheum (2009) 1.03
The association of single and double orphanhood with symptoms of depression among children and adolescents in Namibia. Eur Child Adolesc Psychiatry (2009) 1.02
Effects of a life skills intervention for increasing physical activity in adolescent girls. Arch Pediatr Adolesc Med (2006) 1.02
Symptoms of distress as prospective predictors of pain-related sciatica treatment outcomes. Pain (2006) 1.02
Vision test variability in retinitis pigmentosa and psychosocial factors. Optom Vis Sci (2011) 1.02
Age and risk of pulmonary arterial hypertension in scleroderma. Chest (2003) 1.02
Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality. J Affect Disord (2010) 1.00
A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. Mol Pain (2006) 0.99
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis (2012) 0.98